Home > Drug Search >
  • company_query: Aeras
  •   > 
Drug Filter
Category:
chemistry (2) biology (34)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (25) Phase Ⅰ (7)
Clinical Stage:
Pending (4) Active (27) Discontinued (4)
Bio-Type:
Gene therapy (2) Cell therapy (2) Vaccine (12) Recombinant coagulation factor (2) Recombinant cytokines (1) Other recombinant protein (1) Whole antibody (10) ADC (1) Fusion protein (2)
Indication:
Acute coronary syndrome (ACS) (3) Acute myeloid Leukemia (AML) (1) Anemia (1) Asthma (1) Atherosclerosis (2) Chronic lymphocytic leukemia (CLL) (1) Crohn's disease (1) Gastric cancer (1) HIV infection (1) Leukemia (1) Medulloblastoma (1) Melanoma (2) Multiple myeloma (MM) (2) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (2) Pancreatic cancer (1) Hypoalphalipoproteinaemia (1) Lipid metabolism disorders (1) Prostate cancer (1) Poliomyelitis (1) Psoriasis (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (2) Solid tumours (3) Systemic lupus erythematosus (1) Tuberculosis (8) Colorectal cancer (2) Age-related macular degeneration (AMD) (1) Stroke (2) Type 1 diabetes (1) Hemophilia A (2) Hematological cancer (1) Glioblastoma (1) Graft versus host disease (1) Liposarcoma (1) Plaque psoriasis (1) Sciatica (1) Inflammation (2) Gastrointestinal cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top